According to reports from Prabhudas Lilladher, the brokerage has cut Emami's rating to Hold from a previous rating, while revising the target price down to ₹469 from ₹484 earlier. The recommendation was issued in the research report dated May 21, 2026, reflecting a more cautious outlook on the FMCG company's prospects. The latest report confirms the downgrade while providing updated analysis of the company's performance and growth strategy.
As reported by Prabhudas Lilladher, Emami faced significant headwinds in the fourth quarter, with sales declining by 3.9% and volumes dropping 7% during the period. The company attributed these declines to weak summer conditions and unseasonal rains that impacted consumer demand during the quarter. While the company has reported these figures, the brokerage notes that summer demand has picked up in April/May, suggesting some recovery in recent months.
According to the brokerage's analysis, Emami's near-term outlook remains cautiously optimistic despite current challenges. The company expects healthy demand for FY27 and anticipates growth from acquisition of new brands in Beverage and BPC segments. While summer demand has shown improvement in April and May, IBD (India Business Division) remains a near-term concern for the company. The new acquisitions of Axiom and Incnut are expected to provide a boost to sales, though organic growth in these brands requires monitoring.
As reported by Prabhudas Lilladher, the brokerage estimates sales/EBITDA/EPS CAGR of 10.8%/10%/5.5% over FY26-28 period. The company values the stock at 24x March 2028 EPS, leading to the revised target price of ₹469. The new acquisitions of Axiom and Incnut are expected to provide a flip to sales, though organic growth in these brands needs to be watched carefully. The valuation methodology remains consistent with the previous assessment, reflecting the company's growth prospects despite current market challenges.
